INmune Bio Inc. (INMB)
NASDAQ: INMB
· Real-Time Price · USD
2.53
0.08 (3.27%)
At close: Aug 15, 2025, 3:59 PM
2.47
-2.37%
After-hours: Aug 15, 2025, 07:51 PM EDT
INmune Bio Cash Flow Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Net Income | -55.51M | -40.8M | -42.08M | -41.27M | -37.74M | -34.5M | -30.01M | -27.43M | -26.59M | -26.93M | -27.3M | -31.14M | -32.87M | -32.69M | -30.34M | -23.87M | -19.13M | -14.58M |
Depreciation & Amortization | -24K | n/a | 34K | 34K | 58K | 34K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Stock-Based Compensation | 7.09M | 7.9M | 7.61M | 7.73M | 7.9M | 7.41M | 7.37M | 7.28M | 7.33M | 7.35M | 7.15M | 6.88M | 6.55M | 5.43M | 4.8M | 3.98M | 3.42M | 3.33M |
Other Working Capital | -3K | 915K | 1.38M | -6.25M | -5.2M | -4.24M | 1.91M | 5.57M | 4.85M | 4.75M | -4.27M | -2.08M | -4.56M | -6.18M | -5.35M | -4.32M | -2.71M | -2.53M |
Other Non-Cash Items | 16.56M | 45K | 45K | 84K | 99K | 157K | 224K | 247K | 340K | 339K | 328K | 317K | 223K | 182K | 1.54M | 1.84M | 2.13M | 2.17M |
Deferred Income Tax | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Change in Working Capital | -311K | 140K | 1.04M | 7.68M | 6.66M | 8.58M | 10.44M | 5.63M | 5.55M | 4.28M | -2.86M | -2.83M | -5.23M | -5.21M | -3.09M | -1.29M | -1.19M | -1.75M |
Operating Cash Flow | -32.2M | -32.71M | -33.36M | -25.75M | -23.03M | -18.32M | -11.98M | -14.27M | -13.38M | -14.96M | -22.69M | -26.77M | -31.33M | -32.28M | -28.5M | -21.12M | -16.89M | -13M |
Capital Expenditures | -706K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -15M | -15M | -15M | -15M | n/a |
Cash Acquisitions | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Sales Maturities Of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Investing Acitivies | n/a | n/a | n/a | 2.55M | n/a | n/a | n/a | -2.55M | n/a | n/a | n/a | -15M | -15M | -30M | -30M | -15M | -15M | n/a |
Investing Cash Flow | -706K | n/a | n/a | 2.55M | n/a | n/a | n/a | -1.85M | 699K | n/a | n/a | -15.7M | -15.7M | -30M | -30M | -23.89B | -23.89B | -23.87B |
Debt Repayment | -5M | -7.5M | -10M | -10M | -10M | -7.5M | -5M | -2.5M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 1.01M | 1.01M | 1.01M |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | 12.71M | 12.71M | 12.71M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 30K | 80.28M | 81.42M | 96.37M | 96.36M | 23.91B | 23.91B | 23.9B |
Financial Cash Flow | 35.26M | 25.98M | 18.21M | 17.79M | 6.27M | -6.72M | -4.22M | -2.42M | -699K | -699K | 30K | 729K | 53.67M | 68.62M | 96.36M | 23.97B | 23.94B | 23.92B |
Net Cash Flow | 2.31M | -6.67M | -14.93M | -8.26M | -16.76M | -25M | -16.3M | -15.59M | -13.39M | -15.73M | -22.66M | -27.07M | 21.69M | 21.39M | 52.84M | 60.16M | 34.7M | 39.41M |
Free Cash Flow | -32.9M | -32.71M | -33.36M | -25.75M | -23.03M | -18.32M | -11.98M | -14.27M | -13.38M | -14.96M | -22.69M | -26.77M | -31.33M | -47.28M | -43.5M | -36.12M | -31.89M | -13M |